skip to main content



Catalogue No.


Cell Line Name


Cell Line Description

Established from a squamous cell carcinoma (SCC) of the floor of the mouth (20mm-40mm) of a 40 year-old female patient. STNMP stage III, well differentiated, node positive tumour. Mutant p53, codon 266 exon 8, G to T; wild type K-, N-, and Ha-ras. This cell line is highly responsive to TGFbeta. H376 cells in culture scatter, i.e. the cells redistribute on the substrate, in response to Hepatocyte Growth Factor. Non-tumourigenic in athymic nude mice by subcutaneous injection and on injection into the floor of the mouth (orthotopic). Haplotype information: A*03,A*24; B*27,B*35; Cw*04,Cw*12

General Info



Release Conditions

Restricted - commercial organisations are required to complete the 'Cell Line Release Authorisation for Research Use in Commercial Organisations' release conditions form in the supporting documents section.



TGFbeta type I receptor, TGFbeta II receptor, TGFbeta III receptor

Tissue of Origin

Mouth (floor of)



DNA profile (STR Profile)

Amelogenin: X
CSF1PO: 10,11
D5S818: 10,12
D7S820: 8,10
D13S317: 8,11
D16S539: 11
TH01: 6,9
vWA: 16,18


Not specified


Squamous Cell Carcinoma

Culture Conditions

Cell Type


Subculture Routine

Split sub-confluent cultures (70-80%), approximately every 5-6 days, 1:8 to 1:10 using 0.05% trypsin/EDTA; 5% CO₂; 37°C. Suggested seeding density 5 x 1000 cells/cm².

Culture Medium

DMEM:HAMS F12 (1:1) + 2mM Glutamine + 10% Foetal Bovine Serum (FBS) + 0.5 ug/ml sodium hydrocortisone succinate

Growth Mode


Additional Info


Professor Stephen Prime, Department of Oral & Dental Science, Bristol Dental School, University of Bristol, Lower Maudlin Street, Bristol BS1 2LY

Country of Origin

United Kingdom

Hazard Group (ACDP)

Hazard Group (ACDP) 2



Prime et al., 1994; Int J Cancer 56, 406-412, Prime et al., 1990; J Pathol 160, 259-269, Prime et al., 1994 Br J Cancer 69, 8-15; Yeudall et al., 1993; Eur J Cancer B Oral Oncol 29B, 63-67 & 1995 31B 136-143.


Not Available

Available Formats

  • Frozen
  • DNA-5µg (100ng/µl)

If use of this culture results in a scientific publication, it should be cited in the publication as: H376 (ECACC 06092005).

Unless specified otherwise, at ECACC we routinely handle all of our cell lines at containment level 2 in accordance with the ACDP guidelines (Advisory Committee on Dangerous Pathogens) (UK). All cell cultures have the potential to carry as yet unidentified adventitious agents. It is the responsibility of the end user to ensure that their facilities comply with biosafety regulations for their own country. ACDP Guidance: Biological agents: Managing the risks in laboratories and healthcare premises.

The Culture Collections represent deposits of cultures from world-wide sources. While every effort is made to ensure details distributed by Culture Collections are accurate, Culture Collections cannot be held responsible for any inaccuracies in the data supplied. References where quoted are mainly attributed to the establishment of the cell culture and not for any specific property of the cell line, therefore further references should be obtained regarding cell culture characteristics. Passage numbers where given act only as a guide and Culture Collections does not guarantee the passage number stated will be the passage number received by the customer.

Cultures supplied by Culture Collections are for research purposes only. Enquiries regarding the commercial use of a cell line are referred to the depositor of the cell line. Some cell lines have additional special release conditions such as the requirement for a material transfer agreement to be completed by the potential recipient prior to the supply of the cell line. Please view the Terms & Conditions of Supply for more information.